Citation: |
[1] |
A. Abendroth and A. M. Arvin, Immune evasion as a pathogenic mechanism of varicella zoster virus, Seminars in Immunology, 13 (2001), 27-39.doi: doi:10.1006/smim.2001.0293. |
[2] |
Centers for Disease Control and Prevention, Prevention of varicella: Updated recommendations of the Advisory Committee on Immunization Practices (ACIP), Morbidity and Mortality Weekly Report, 48, 1999. |
[3] |
Centers for Disease Control and Prevention, Prevention of herpes zoster, Morbidity and Mortality Weekly Report, 57, 2008. |
[4] |
J. I. Cohen, S. E. Straus and A. M. Arvin, Varicella-zoster virus replication, pathogenesis and management, in "Field's Virology" (eds. D. M. Knipe and P. M. Howley), Wolters Kluwer Health/Lippincott Williams and Wilkins, (2007), 2773-2818. |
[5] |
D. H. Gilden, R. J. Cohrs and R. Mahalingam, Clinical and molecular pathogenesis of varicella virus infection, Viral Immunology, 16 (2003), 243-258. |
[6] |
R. E. Hope-Simpson, The nature of herpes zoster: A long-term study and a new hypothesis, Proc. R. Soc. Med., 58 (1965), 9-20. |
[7] |
R. E. Hope-Simpson, Post-herpetic neuralgia, Journal of the Royal College of General Practitioners, 25 (1975), 571-575. |
[8] |
M. J. Levin, D Barber, E. Goldblatt, M. Jones, B. LaFleur, C. Chan, D. Stinson, G. O. Zerbe and A. R. Hayward, Use of a live attenuated varicella vaccine to boost varicella-specific immune responses in seropositive people 55 years of age or older: Duration of booster effect, The Journal of Infectious Diseases, 178 (suppl. 1) (1998), S109-S112. |
[9] |
M. J. Levin, J. G. Smith, R. M. Kaufhold, D. Barber, A. R. Hayward, C. Y. Chan, I. S. F. Chan, D. J. J. Li, W. Wang, P. M. Keller, A. Shaw, J. L. Silber, K. Schlienger, I. Chalikonda, S. J. R. Vessey and M. J. Caulfield, Decline of varicella zoster virus (VZV)-specific cell mediated immunity with increasing age and boosting with a high-dose VZV vaccine, The Journal of Infectious Diseases, 188 (2003), 1336-1344. |
[10] |
M. Reichelt, L. Zerboni and A.M. Arvin, Mechansisms of varicella-zoster virus neuropathogenesis in human dorsal root ganglia, Journal of Virology, 82 (2008), 3971-3983.doi: doi:10.1128/JVI.02592-07. |
[11] |
K. E. Schmader and R. H. Dworkin, Natural history and treatment of herpes zoster, The Journal of Pain, 9 (suppl. 1) (2008), 53-59.doi: doi:10.1016/j.jpain.2007.10.002. |
[12] |
S. L. Thomas, J. G. Wheeler and A. J. Hall, Contacts with varicella or with children and protection against herpes zoster in adults: A case-control study, The Lancet, 360 (2002), 678-682. |
[13] |
J. M. Weinberg., Herpes zoster: Epidemiology, natural history and common complications, Journal of the American Academy of Dermatology, 57 (2007), S130-S135.doi: doi:10.1016/j.jaad.2007.08.046. |
[14] |
A. Wilson, M. Sharp, C. M. Koropchak, S. F. Ting and A. M. Arvin, Subclinical varicella-zoster virus viremia, herpes zoster, and T lymphocyte immunity to varicella-zoster viral antigens after bone marrow transplants, Journal of Infectious Diseases, 165 (1992), 119-126. |